Header Logo

Connection

Erin Hahn to Female

This is a "connection" page, showing publications Erin Hahn has written about Female.
Connection Strength

0.719
  1. Century-old chromatin architecture revealed in formalin-fixed vertebrates. Nat Commun. 2024 Jul 29; 15(1):6378.
    View in: PubMed
    Score: 0.080
  2. Barriers and facilitators to implementation and sustainment of guideline-recommended depression screening for patients with breast cancer in medical oncology: a qualitative study. Support Care Cancer. 2023 Jul 12; 31(8):461.
    View in: PubMed
    Score: 0.075
  3. Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial. JAMA. 2022 01 04; 327(1):41-49.
    View in: PubMed
    Score: 0.067
  4. A Patient Portal-Based Commitment Device to Improve Adherence with Screening for Colorectal Cancer: a Retrospective Observational Study. J Gen Intern Med. 2021 04; 36(4):952-960.
    View in: PubMed
    Score: 0.063
  5. Anxiety, Culture, and Expectations: Oncologist-Perceived Factors Associated With Use of Nonrecommended Serum Tumor Marker Tests for Surveillance of Early-Stage Breast Cancer. J Oncol Pract. 2017 01; 13(1):e77-e90.
    View in: PubMed
    Score: 0.047
  6. Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care? Cancer. 2016 Mar 15; 122(6):908-16.
    View in: PubMed
    Score: 0.044
  7. Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation. J Oncol Pract. 2015 May; 11(3):e320-8.
    View in: PubMed
    Score: 0.042
  8. Post-traumatic stress symptoms in cancer survivors: relationship to the impact of cancer scale and other associated risk factors. Psychooncology. 2015 Jun; 24(6):643-52.
    View in: PubMed
    Score: 0.040
  9. Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors. Cancer. 2013 Dec 15; 119(24):4316-24.
    View in: PubMed
    Score: 0.038
  10. Provider perceptions and expectations of breast cancer posttreatment care: a University of California Athena Breast Health Network project. J Cancer Surviv. 2013 Sep; 7(3):323-30.
    View in: PubMed
    Score: 0.036
  11. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008 Feb 10; 26(5):759-67.
    View in: PubMed
    Score: 0.026
  12. Primary Human Papillomavirus Screening: Women's Perceptions of New Cervical Cancer Screening Recommendations. J Womens Health (Larchmt). 2024 Dec; 33(12):1614-1624.
    View in: PubMed
    Score: 0.020
  13. Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing. Cancer Epidemiol Biomarkers Prev. 2024 Feb 06; 33(2):215-223.
    View in: PubMed
    Score: 0.019
  14. Racial and Ethnic Bias in Risk Prediction Models for Colorectal Cancer Recurrence When Race and Ethnicity Are Omitted as Predictors. JAMA Netw Open. 2023 Jun 01; 6(6):e2318495.
    View in: PubMed
    Score: 0.018
  15. A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care system. Contemp Clin Trials. 2023 01; 124:106994.
    View in: PubMed
    Score: 0.018
  16. Laboratory monitoring to reduce adverse drug-related events: a mixed methods study. J Manag Care Spec Pharm. 2022 Jan; 28(1):16-25.
    View in: PubMed
    Score: 0.017
  17. Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21-65 Years in a Large Integrated Health Care System - Southern California, January 1-September 30, 2019, and January 1-September 30, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 29; 70(4):109-113.
    View in: PubMed
    Score: 0.016
  18. Personalized Cancer Follow-Up Care Pathways: A Delphi Consensus of Research Priorities. J Natl Cancer Inst. 2020 12 14; 112(12):1183-1189.
    View in: PubMed
    Score: 0.016
  19. Follow-up of Abnormal Estimated GFR Results Within a Large Integrated Health Care Delivery System: A Mixed-Methods Study. Am J Kidney Dis. 2019 11; 74(5):589-600.
    View in: PubMed
    Score: 0.014
  20. Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer. Ann Am Thorac Soc. 2017 Oct; 14(10):1571-1580.
    View in: PubMed
    Score: 0.012
  21. Quality of Posttreatment Care Among Breast Cancer Survivors in the University of California Athena Breast Health Network (Athena). Clin Breast Cancer. 2016 10; 16(5):356-363.
    View in: PubMed
    Score: 0.011

© 2024 Kaiser Permanente